Evidence map›Paper›PMID 39508753›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

Virtual care in patients with type 2 diabetes during covid-19

Héctor Velázquez-Jurado, Liliana Pérez-Peralta, Daniela Valle-Nava, Nancy Reynoso-Noverón, Sergio Hernández-Jiménez, Denise Arcila-Martínez, Rodrigo Arizmendi-Rodríguez, Fernanda Garnica-Carrillo

Abstract readComparative Study
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Héctor Velázquez-JuradoSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0000-0002-7660-9336
Liliana Pérez-PeraltaSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0000-0003-1633-8164b
Daniela Valle-NavaSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0000-0002-7832-1125c
Nancy Reynoso-NoverónSecretaría de Salud, Instituto Nacional de Cancerología, Centro de Investigación en Prevención. Ciudad de México, México.ORCID 0000-0002-7784-2287d
Sergio Hernández-JiménezSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0000-0003-3080-8708e
Denise Arcila-MartínezSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0000-0001-6382-3897f
Rodrigo Arizmendi-RodríguezSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0000-0003-2786-2164g
Fernanda Garnica-CarrilloSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.ORCID 0009-0004-9242-2637h

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The covid-19 pandemic made self-management difficult for people with type 2 diabetes mellitus (T2DM). Some health services provided remote care to people with chronic illnesses. Objective: To compare the modalities of care, in-person (AP) versus virtual (AV), during the covid-19 pandemic on clinical and mental health variables. Material and methods: Prospective cohort study of 75 patients with a diagnosis of DM2 (age Me = 49 years) treated between June 2020 and December 2021. A total of 40 (53%) received VA and 35 (47%) AP. The Chi square and Mann-Whitney U statistical tests were used to show homogeneity between groups and the Friedman test to compare the pre- and post-test change, considering each attention group as a comparison factor. Results: In both groups the values ​​of HbA1c, triglycerides and Non-HDL cholesterol decreased. Both groups improved in quality of life and emotional exhaustion. A Cox regression model showed that the perception of a good quality of life and triglyceride control at two months increase the HR of HbA1c control, after adjusting the model for age and sex. Conclusions: Both care modalities generate a similar benefit in the management of T2DM. The virtual consultation was a useful and safe alternative.

Indexed as

COVID-19Diabetes Mellitus, Type 2TelemedicineAdultAgedFemaleGlycated HemoglobinHumansMaleMexicoMiddle AgedProspective StudiesQuality of LifeSARS-CoV-2Glycated HemoglobinGlycosylated HemoglobinQuality of LifeSARS-CoV-2Telemedicine

Identifiers

PMID39508753
PMCPMC12129566

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.